KardiaMobile 6L can be used to measure QT duration in COVID-19 patients - Cardiac Rhythm News

KardiaMobile 6L, which it describes in a press release as the world’s only six lead personal ECG.

AliveCor (@AliveCor) / X

A comparison of ECG-based home monitoring devices in adults with CHD, Cardiology in the Young

COVID-19 Archives - Cardiac Rhythm News

New FDA guidance allows use of KardiaMobile 6L to measure QTc in COVID-19 patients

Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device

Mayo Clinic research yields breakthrough in mobile determination of QT prolongation - Mayo Clinic News Network

COVID-19 Archives - Cardiac Rhythm News

2021 ISHNE/ HRS/ EHRA/ APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals - Varma - 2021 - Annals of Noninvasive Electrocardiology - Wiley Online Library

RApid Throughput Screening for Asymptomatic COVID-19 Infection With an Electrocardiogram: A Prospective Observational Study - Mayo Clinic Proceedings: Digital Health

Implementation of a fully remote randomized clinical trial with cardiac monitoring

Hearts, Free Full-Text

A comparison of ECG-based home monitoring devices in adults with CHD, Cardiology in the Young

Southwest Journal of Pulmonary, Critical Care and Sleep - Pulmonary - Home-Based Physiological Monitoring of Patients with COVID-19

Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients